Yu E Xue, Dongmei Zhang, Shuaixian Du, Du Chen, Shihan Liu, Tianfeng Peng, Chong Li, Jianchu Zhang, Xiaorong Wang
{"title":"住院患者携带bla imp -4肺炎克雷伯菌ST-11的分子流行病学特征","authors":"Yu E Xue, Dongmei Zhang, Shuaixian Du, Du Chen, Shihan Liu, Tianfeng Peng, Chong Li, Jianchu Zhang, Xiaorong Wang","doi":"10.2147/IDR.S482713","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the molecular epidemiology and risk factors of carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) infection.</p><p><strong>Patients and methods: </strong>Patient's clinical data and CRKP strains were collected from November 2017 to December 2018 at a tertiary hospital in Wuhan, China. The antimicrobial susceptibilities, carbapenem-resistant genes, multi-locus sequence typing (MLST), homologous analysis, and risk factors for CRKP were determined.</p><p><strong>Results: </strong>A total of 203 CRKP strains were isolated, and 98.5% (200/203) of patients were nosocomially infected. The mortality rate was 17.7% (36/203). All 203 strains were confirmed as carbapenemases -producing strains. The most predominant carbapenemase gene was <i>bla</i> <sub>IMP-4</sub> (81.3%, 165/203), followed by <i>bla</i> <sub>KPC-2</sub> (25.1%, 51/203) and <i>bla</i> <sub>NDM-1</sub> (23.2%, 47/205). Of the 203 strains, 28 (13.8%) had both <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>IMP-4</sub> genes, 23 (11.3%) had both <i>bla</i> <sub>IMP-4</sub> and <i>bla</i> <sub>NDM-1</sub> genes, 20 (9.9%) had <i>bla</i> <sub>KPC-2</sub>, <i>bla</i> <sub>IMP-4</sub> and <i>bla</i> <sub>NDM-1</sub> three genes. MLST analysis showed that there were 48 ST typologies (including 7 new STs), of which ST-11 was the most prevalent (59.6%, 121/203). Phylogenetic analysis showed that 203 CRKP isolates came from 7 clusters and exhibited a strong correlation with the isolation source. eBURST analyses indicated that CRKP isolates have undergone different evolutionary processes. Patients with ST-11 CRKP underwent more mechanical ventilation (50% vs 32.9%, <i>P</i>=0.020) and gastric catheterization (15.7% vs 6.1%, <i>P</i>=0.042) within 3 months before sample collection, and also had higher drug-resistance rate than non-ST-11 CRKP. Comparing with CSKP (carbapenem-sensitive <i>Klebsiella pneumoniae</i>), gastrointestinal disease (odds ratio [OR]=6.168, <i>P</i>=0.003), nosocomial infection (OR=5.573, <i>P</i>=0.012), antibiotic exposure (OR=4.131, <i>P</i>=0.004), urinary catheterization (OR=3.960, <i>P</i>=0.031) and venous/arterial catheterization (OR=2.738, <i>P</i>=0.026) within the preceding 3 months were independent risk factors for CRKP infection.</p><p><strong>Conclusion: </strong>The IMP-4 was the most predominant carbapenemase and <i>bla</i> <sub>IMP-4</sub> bearing <i>Klebsiella pneumoniae</i> ST-11 was spreading in the hospital. Nosocomial infections, antibiotic exposure, and urinary and venous/arterial catheterization within 3 months were the risk factors for developing CRKP infection.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"171-184"},"PeriodicalIF":2.9000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725253/pdf/","citationCount":"0","resultStr":"{\"title\":\"Molecular Epidemiological Characteristics of <i>bla</i> <sub>IMP-4</sub>-Carrying <i>Klebsiella pneumoniae</i> ST-11 in Hospitalized Patients.\",\"authors\":\"Yu E Xue, Dongmei Zhang, Shuaixian Du, Du Chen, Shihan Liu, Tianfeng Peng, Chong Li, Jianchu Zhang, Xiaorong Wang\",\"doi\":\"10.2147/IDR.S482713\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To investigate the molecular epidemiology and risk factors of carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) infection.</p><p><strong>Patients and methods: </strong>Patient's clinical data and CRKP strains were collected from November 2017 to December 2018 at a tertiary hospital in Wuhan, China. The antimicrobial susceptibilities, carbapenem-resistant genes, multi-locus sequence typing (MLST), homologous analysis, and risk factors for CRKP were determined.</p><p><strong>Results: </strong>A total of 203 CRKP strains were isolated, and 98.5% (200/203) of patients were nosocomially infected. The mortality rate was 17.7% (36/203). All 203 strains were confirmed as carbapenemases -producing strains. The most predominant carbapenemase gene was <i>bla</i> <sub>IMP-4</sub> (81.3%, 165/203), followed by <i>bla</i> <sub>KPC-2</sub> (25.1%, 51/203) and <i>bla</i> <sub>NDM-1</sub> (23.2%, 47/205). Of the 203 strains, 28 (13.8%) had both <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>IMP-4</sub> genes, 23 (11.3%) had both <i>bla</i> <sub>IMP-4</sub> and <i>bla</i> <sub>NDM-1</sub> genes, 20 (9.9%) had <i>bla</i> <sub>KPC-2</sub>, <i>bla</i> <sub>IMP-4</sub> and <i>bla</i> <sub>NDM-1</sub> three genes. MLST analysis showed that there were 48 ST typologies (including 7 new STs), of which ST-11 was the most prevalent (59.6%, 121/203). Phylogenetic analysis showed that 203 CRKP isolates came from 7 clusters and exhibited a strong correlation with the isolation source. eBURST analyses indicated that CRKP isolates have undergone different evolutionary processes. Patients with ST-11 CRKP underwent more mechanical ventilation (50% vs 32.9%, <i>P</i>=0.020) and gastric catheterization (15.7% vs 6.1%, <i>P</i>=0.042) within 3 months before sample collection, and also had higher drug-resistance rate than non-ST-11 CRKP. Comparing with CSKP (carbapenem-sensitive <i>Klebsiella pneumoniae</i>), gastrointestinal disease (odds ratio [OR]=6.168, <i>P</i>=0.003), nosocomial infection (OR=5.573, <i>P</i>=0.012), antibiotic exposure (OR=4.131, <i>P</i>=0.004), urinary catheterization (OR=3.960, <i>P</i>=0.031) and venous/arterial catheterization (OR=2.738, <i>P</i>=0.026) within the preceding 3 months were independent risk factors for CRKP infection.</p><p><strong>Conclusion: </strong>The IMP-4 was the most predominant carbapenemase and <i>bla</i> <sub>IMP-4</sub> bearing <i>Klebsiella pneumoniae</i> ST-11 was spreading in the hospital. Nosocomial infections, antibiotic exposure, and urinary and venous/arterial catheterization within 3 months were the risk factors for developing CRKP infection.</p>\",\"PeriodicalId\":13577,\"journal\":{\"name\":\"Infection and Drug Resistance\",\"volume\":\"18 \",\"pages\":\"171-184\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725253/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infection and Drug Resistance\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/IDR.S482713\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S482713","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Molecular Epidemiological Characteristics of blaIMP-4-Carrying Klebsiella pneumoniae ST-11 in Hospitalized Patients.
Purpose: To investigate the molecular epidemiology and risk factors of carbapenem-resistant Klebsiella pneumoniae (CRKP) infection.
Patients and methods: Patient's clinical data and CRKP strains were collected from November 2017 to December 2018 at a tertiary hospital in Wuhan, China. The antimicrobial susceptibilities, carbapenem-resistant genes, multi-locus sequence typing (MLST), homologous analysis, and risk factors for CRKP were determined.
Results: A total of 203 CRKP strains were isolated, and 98.5% (200/203) of patients were nosocomially infected. The mortality rate was 17.7% (36/203). All 203 strains were confirmed as carbapenemases -producing strains. The most predominant carbapenemase gene was blaIMP-4 (81.3%, 165/203), followed by blaKPC-2 (25.1%, 51/203) and blaNDM-1 (23.2%, 47/205). Of the 203 strains, 28 (13.8%) had both blaKPC-2 and blaIMP-4 genes, 23 (11.3%) had both blaIMP-4 and blaNDM-1 genes, 20 (9.9%) had blaKPC-2, blaIMP-4 and blaNDM-1 three genes. MLST analysis showed that there were 48 ST typologies (including 7 new STs), of which ST-11 was the most prevalent (59.6%, 121/203). Phylogenetic analysis showed that 203 CRKP isolates came from 7 clusters and exhibited a strong correlation with the isolation source. eBURST analyses indicated that CRKP isolates have undergone different evolutionary processes. Patients with ST-11 CRKP underwent more mechanical ventilation (50% vs 32.9%, P=0.020) and gastric catheterization (15.7% vs 6.1%, P=0.042) within 3 months before sample collection, and also had higher drug-resistance rate than non-ST-11 CRKP. Comparing with CSKP (carbapenem-sensitive Klebsiella pneumoniae), gastrointestinal disease (odds ratio [OR]=6.168, P=0.003), nosocomial infection (OR=5.573, P=0.012), antibiotic exposure (OR=4.131, P=0.004), urinary catheterization (OR=3.960, P=0.031) and venous/arterial catheterization (OR=2.738, P=0.026) within the preceding 3 months were independent risk factors for CRKP infection.
Conclusion: The IMP-4 was the most predominant carbapenemase and blaIMP-4 bearing Klebsiella pneumoniae ST-11 was spreading in the hospital. Nosocomial infections, antibiotic exposure, and urinary and venous/arterial catheterization within 3 months were the risk factors for developing CRKP infection.
期刊介绍:
About Journal
Editors
Peer Reviewers
Articles
Article Publishing Charges
Aims and Scope
Call For Papers
ISSN: 1178-6973
Editor-in-Chief: Professor Suresh Antony
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.